Is whole-body FDG-PET valuable for health screening? Against

Eur J Nucl Med Mol Imaging. 2005 Mar;32(3):342-3. doi: 10.1007/s00259-005-1775-2.
No abstract available

MeSH terms

  • Fluorodeoxyglucose F18*
  • Humans
  • Mass Screening / methods*
  • Neoplasms / diagnostic imaging*
  • Positron-Emission Tomography / methods*
  • Positron-Emission Tomography / statistics & numerical data
  • Practice Guidelines as Topic
  • Practice Patterns, Physicians'
  • Radiopharmaceuticals
  • Whole-Body Counting / methods*

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18